Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Tbx3 impinges on the p53 pathway to suppress apoptosis, facilitate cell transformation and block myogenic differentiation

Abstract

Tbx3 is a member of the T-box family of transcription factors. Mutations in Tbx3 cause ulnar-mammary syndrome, an autosomal dominant disorder characterized by upper limb defects, apocrine-gland defects including mammary hypoplasia, and tooth, hair and genital defects. In cell culture, Tbx3 and its close relative Tbx2 are capable of immortalizing mouse embryo fibroblasts. We show that expression of Tbx3 together with Myc or oncogenic Ras (H-RasVal17) leads to efficient transformation of mouse embryo fibroblasts. Oncogene cooperation by Tbx3 correlates with an ability of Tbx3 to suppress the induction of p19ARF and p53 that is typically caused by overexpression Myc and Ras, and to protect against Myc-induced apoptosis. Whereas Tbx3 is capable of interfering with apoptosis caused by excessive Myc levels, a Tbx3 mutant lacking its C-terminal repression domain shows no anti-apoptotic activity and fails to repress levels of p19ARF or p53. Consistent with an ability to suppress p53 pathway function, we find that Tbx3, but not a Tbx3 C-terminal mutant, efficiently blocks myogenic differentiation of C2C12 myoblasts. Our results support the idea that deregulation and/or excessive levels of Tbx3 may have oncogenic potential in vivo.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Agulnik SI, Garvey N, Hancock S, Ruvinsky I, Chapman DL, Agulnik I, Bollag R, Papaioannou V, Silver LM . 1996 Genetics 144: 249–254

  • Bamshad M, Lin RC, Law D, Watkins WC, Krakowiak PA, Moore ME, Franceschini P, Lala R, Holmes LB, Gebuhr TC, Bruneau BG, Schinzel A, Seidman JG, Seidman CE, Jorde LB . 1997 Nat. Genet. 16: 311–315

  • Bamshad M, Le T, Watkins WS, Dixon ME, Kramer BE, Roeder AD, Carey JC, Root S, Schinzel A, Van Maldergem L, Gardner RJ, Lin RC, Seidman CE, Seidman JG, Wallerstein R, Moran E, Sutphen R, Campbell CE, Jorde LB . 1999 Am. J. Hum. Genet. 64: 1550–1562

  • Basson CT, Bachinsky DR, Lin RC, Levi T, Elkins JA, Soults J, Grayzel D, Kroumpouzou E, Traill TA, Leblanc-Straceski J, Renault B, Kucherlapati R, Seidman JG, Seidman CE . 1997 Nat. Genet. 15: 30–35

  • Braybrook C, Doudney K, Marcano AC, Arnason A, Bjornsson A, Patton MA, Goodfellow PJ, Moore GE, Stanier P . 2001 Nat. Genet. 29: 179–183

  • Brummelkamp TR, Kortlever RM, Lingbeek M, Trettel F, MacDonald ME, van Lohuizen M, Bernards R . 2002 J. Biol. Chem. 277: 6567–6572

  • Carlson H, Ota S, Campbell CE, Hurlin PJ . 2001 Hum. Mol. Genet. 10: 2403–2413

  • Cerone MA, Marchetti A, Bossi G, Blandino G, Sacchi A, Soddu S . 2000 Cell Death Differ. 7: 506–508

  • Celli J, Duijf P, Hamel BC, Bamshad M, Kramer B, Smits AP, Newbury-Ecob R, Hennekam RC, Van Buggenhout G, van Haeringen A, Woods CG, van Essen AJ, de Waal R, Vriend G, Haber DA, Yang A, McKeon F, Brunner HG, van Bokhoven H . 1999 Cell 99: 143–153

  • Chapman DL, Garvey N, Hancock S, Alexiou M, Agulnik SI, Gibson-Brown JJ, Cebra-Thomas J, Bollag RJ, Silver LM, Papaioannou VE . 1996 Dev. Dyn. 206: 379–390

  • Chen CA, Okayama H . 1988 Biotechniques 6: 632–638

  • Eischen CM, Weber JD, Roussel MF, Sherr CJ, Cleveland JL . 1999 Genes Dev. 13: 2658–2669

  • Evan GI, Vousden KH . 2001 Nature 411: 342–348

  • Gibson-Brown JJ, I Agulnik S, Silver LM, Papaioannou VE . 1998 Mech. Dev. 74: 165–169

  • He Ml, Wen L, Campbell CE, Wu JY, Rao Y . 1999 Proc. Natl. Acad. Sci. USA 96: 10212–10217

  • Herrmann BG, Labeit S, Poustka A, King TR, Lehrach H . 1990 Nature 343: 617–622

  • Hurlin PJ, Fry DG, Maher VM, McCormick JJ . 1987 Cancer Res. 47: 5752–5757

  • Ianakiev P, Kilpatrick MW, Toudjarska I, Basel D, Beighton P, Tsipouras P . 2000 Am. J. Hum. Genet. 67: 59–66

  • Jacobs JJ, Scheijen B, Voncken JW, Kieboom K, Berns A, van Lohuizen M . 1999 Genes Dev. 13: 2678–2690

  • Jacobs JJ, Keblusek P, Robanus-Maandag E, Kristel P, Lingbeek M, Nederlof PM, van Welsem T, van de Vijver MJ, Koh EY, Daley GQ, van Lohuizen M . 2000 Nat. Genet. 26: 291–299

  • Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G, Sherr CJ . 1997 Cell 91: 649–659

  • Land H, Parada LF, Weinberg RA . 1983 Nature 304: 596–602

  • Li QY, Newbury-Ecob RA, Terrett JA, Wilson DI, Curtis AR, Yi CH, Gebuhr T, Bullen PJ, Robson SC, Strachan T, Bonnet D, Lyonnet S, Young ID, Raeburn JA, Buckler AJ, Law DJ, Brook JD . 1997 Nat. Genet. 15: 1–9

  • Maestro R, Dei Tos AP, Hamamori Y, Krasnokutsky S, Sartorelli V, Kedes L, Doglioni C, Beach DH, Hannon GJ . 1999 Genes Dev. 13: 2207–2217

  • Mateyak MK, Obaya AJ, Sedivy JM . 1999 Mol. Cell. Biol. 19: 4672–4683

  • McGrath JA, Duijf PH, Doetsch V, Irvine AD, de Waal R, Vanmolkot KR, Wessagowit V, Kelly A, Atherton D, Griffiths WA, Orlow SJ, van Haeringen A, Ausems MG, Yang A, McKeon F, Bamshad MA, Brunner HG, Hamel BC, van Bokhoven H . 2001 Hum. Mol. Genet. 10: 221–229

  • Palmero I, Pantoja C, Serrano M . 1998 Nature 395: 125–126

  • Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW . 1997 Cell 88: 593–602

  • Schinke M, Izumo S . 2001 Nat. Genet. 27: 238–240

  • Schinzel A . 1987 J. Med. Genet. 24: 778–781

  • Sharpless NE, DePinho RA . 1999 Curr. Opin. Genet. Dev. 9: 22–30

  • Sherr CJ, Weber JD . 2000 Curr. Opin. Genet. Dev. 10: 949–953

  • Smith J . 1999 Trends Genet. 15: 154–158

  • Spector D, Goldman RD, Leinwand LA . 1998 Cells, a laboratory manual Vol. 1: New York: Cold Spring Harbor Press

    Google Scholar 

  • Tao W, Levine AJ . 1999 Proc. Natl. Acad. Sci. USA 96: 6937–6941

  • van Bokhoven H, Hamel BC, Bamshad M, Sangiorgi E, Gurrieri F, Duijf PH, Vanmolkot KR, van Beusekom E, van Beersum SE, Celli J, Merkx GF, Tenconi R, Fryns JP, Verloes A, Newbury-Ecob RA, Raas-Rotschild A, Majewski F, Beemer FA, Janecke A, Chitayat D, Crisponi G, Kayserili H, Yates JR, Neri G, Brunner HG . 2001 Am. J. Hum. Genet. 69: 481–492

  • Walsh K, Perlman H . 1997 Curr. Opin. Genet. Dev. 7: 597–602

  • Welch PJ, Wang JY . 1993 Cell 75: 779–790

  • Welch PJ, Wang JY . 1995 Mol. Cell. Biol. 15: 5542–5551

  • Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ, Roussel MF . 1998 Genes Dev. 12: 2424–2433

Download references

Acknowledgements

We would like to thank Scott Lowe, Arnold Levine, John Sedivy, Carla Grandori and Robert Eisenman for reagents. This work was supported by a grant from Shriners Hospitals for Children to PJ Hurlin.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter J Hurlin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carlson, H., Ota, S., Song, Y. et al. Tbx3 impinges on the p53 pathway to suppress apoptosis, facilitate cell transformation and block myogenic differentiation. Oncogene 21, 3827–3835 (2002). https://doi.org/10.1038/sj.onc.1205476

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205476

Keywords

This article is cited by

Search

Quick links